YOLFTbeta
30

Walvax BioTech

300142 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

10.77CNY-0.24 (-2.18%)

Price History

Full chart

Market Stats

Previous Close11.01
Open10.97
Day Range10.73 – 11.06
52-Week Range10.74 – 16.97
Volume34.85M
Market Cap22.76B
P/E (TTM)118.58
Forward P/E37.31
EPS0.12
Dividend Yield1.09%
Beta0.62
50-Day Avg13.36
200-Day Avg12.70

About

Walvax Biotechnology Co., Ltd., engages in the research and development, manufacture, and distribution of vaccines in China and internationally. Its vaccine portfolio includes recombinant human papillomavirus bivalent, 13-valent pneumococcal polysaccharide conjugate, 23-valent pneumococcal polysaccharide, group ACYW135 meningococcal polysaccharide, group A and C meningococcal polysaccharide, group A and group C meningococcal conjugate, and haemophilus influenzae type b conjugate vaccines, as well as diphtheria, tetanus and acellular pertussis combined vaccine. The company was founded in 2001 and is headquartered in Kunming, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Wei Yao
  • Employees1.98K
  • HeadquartersNo. 395 Kexin Road, Kunming, China, 650101, China
  • Websitehttps://www.walvax.com

Leadership

  • Mr. Wei YaoPresident & Director · b. 1972
  • Dr. Shaozhong DongVice Chairman & VP · b. 1968
  • Mr. Changxiong WuAccounting Supervisor & CFO · b. 1983
  • Ms. Yun Yan WuDirector of Operations · b. 1982
  • Mr. Qingtang DuanEngineering Director · b. 1982
  • Mr. Ming Bo SunVP & Director · b. 1969
  • Mr. Ye YanVP & Board Secretary · b. 1984
  • Ms. Wei LiVice President · b. 1987

Financials

Income Statement

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue129.36M184.06M239.13M358.79M470.17M537.56M583.09M719.02M1.01B591.00M668.26M874.32M1.12B2.94B3.46B5.09B4.11B2.82B2.41B
Growth (%)-+42.28%+29.92%+50.04%+31.04%+14.33%+8.47%+23.31%+39.92%-41.25%+13.07%+30.83%+28.24%+162.13%+17.82%+46.89%-19.12%-31.41%-14.57%
Cost of Revenue63.25M38.90M32.61M32.72M41.90M72.86M169.60M420.00M607.08M318.72M220.00M182.65M235.20M404.53M403.54M673.14M749.39M740.48M750.78M
Gross Profit66.11M145.16M206.52M326.07M431.91M464.70M413.50M299.02M398.95M272.28M448.27M691.67M886.02M2.53B3.06B4.41B3.36B2.08B1.66B
Gross Margin51.10%78.87%86.36%90.88%91.86%86.45%70.91%41.59%39.66%46.07%67.08%79.11%79.02%86.24%88.35%86.77%81.78%73.76%68.85%
Operating Expense60.56M110.00M102.34M149.19M234.20M242.01M409.99M170.86M1.30B432.02M592.40M559.94M653.14M1.16B2.35B3.31B2.75B1.98B1.59B
Operating Income5.55M35.16M104.18M176.88M197.71M222.69M3.51M128.16M-898.16M-159.74M-144.13M131.73M232.88M1.38B710.28M1.10B613.97M96.67M69.96M
Operating Margin4.29%19.10%43.57%49.30%42.05%41.43%0.60%17.82%-89.28%-27.03%-21.57%15.07%20.77%46.83%20.51%21.62%14.92%3.43%2.90%
EBITDA13.64M57.58M109.11M199.28M265.20M261.05M176.10M-149.52M-161.58M-11.95M16.40M241.87M248.11M1.15B927.65M1.42B1.12B387.61M481.71M
EBITDA Margin10.54%31.28%45.63%55.54%56.40%48.56%30.20%-20.79%-16.06%-2.02%2.45%27.66%22.13%39.06%26.79%27.96%27.25%13.74%19.99%
Net Income7.42M34.70M76.33M154.42M207.54M232.80M47.89M143.42M-840.90M70.46M-537.14M1.05B141.97M1.00B427.75M728.65M419.39M142.16M177.74M
Net Income Margin5.74%18.85%31.92%43.04%44.14%43.31%8.21%19.95%-83.59%11.92%-80.38%119.66%12.66%34.13%12.35%14.33%10.19%5.04%7.37%
R&D5.65M7.50M11.03M18.52M33.55M28.90M27.45M96.36M232.48M127.22M99.01M142.17M64.81M176.49M621.49M932.89M776.43M599.78M224.19M
R&D as % of Total Revenue4.36%4.08%4.61%5.16%7.14%5.38%4.71%13.40%23.11%21.53%14.82%16.26%5.78%6.01%17.95%18.34%18.87%21.26%9.30%
Interest Expense1.10M4.11M2.82M4.82M3.16M9.97M70.57M172.80M154.04M137.10M115.59M39.98M32.67M2.08M6.47M7.86M3.81M8.75M2.22M
Interest Expense % of Total Revenue0.85%2.23%1.18%1.34%0.67%1.85%12.10%24.03%15.31%23.20%17.30%4.57%2.91%0.07%0.19%0.15%0.09%0.31%0.09%

Balance Sheet

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets217.52M301.90M386.12M2.99B3.01B4.45B6.14B5.97B6.26B6.32B5.88B7.24B7.02B9.65B13.67B15.34B15.59B14.72B12.07B
Total Liabilities199.86M203.54M211.43M435.52M293.62M1.28B3.20B2.76B3.23B2.80B2.32B1.98B1.35B1.80B3.68B4.35B4.19B3.22B2.26B
Total Equity17.66M98.36M174.69M2.55B2.71B2.95B2.74B2.88B2.28B3.21B3.03B4.58B4.87B6.54B8.48B9.08B9.35B9.43B8.62B
Cash26.42M33.58M79.53M2.34B1.99B1.42B1.23B584.21M1.03B1.42B1.21B2.48B2.38B1.96B3.44B3.87B4.36B3.76B1.35B
Total Debt52.00M63.00M107.28M188.28M53.28M537.00M2.16B2.03B1.46B280.00M476.01M210.93M-42.04M311.06M439.16M775.76M445.10M427.43M
Net Debt25.58M29.42M27.76M-2.15B-1.99B-885.59M925.65M1.44B428.05M-1.14B-735.22M-2.27B-2.38B-1.92B-3.13B-3.43B-3.59B-3.32B-925.29M

Cash Flow

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow31.85M-5.69M82.18M86.71M91.98M78.38M-121.73M-65.93M-69.41M-89.94M-10.13M-65.23M62.02M114.19M705.28M1.20B1.13B1.04B494.37M
Investing Cash Flow-18.18M-39.39M-77.24M-164.81M-209.26M-1.07B-1.43B-250.32M-451.16M110.56M-14.44M619.14M193.00M-730.00M-977.15M-935.19M-810.28M-1.27B-2.01B
Financing Cash Flow4.70M42.25M51.01M2.34B-229.12M416.43M1.36B-329.50M928.95M401.58M-189.00M711.70M-360.64M215.08M1.74B94.82M236.64M-371.03M-894.58M
Capital Expenditure18.26M29.39M74.75M164.81M197.56M355.87M389.67M240.39M264.75M250.24M331.06M227.32M351.82M407.13M1.10B1.09B945.52M550.03M509.54M
Free Cash Flow13.59M-35.08M7.43M-78.10M-105.58M-277.49M-511.40M-306.33M-334.16M-340.17M-388.11M-292.55M-289.81M-292.94M-398.21M110.31M188.25M486.49M-15.17M
Dividends Paid2.04M3.95M3.83M4.50M48.90M58.76M98.31M173.97M154.67M126.13M34.31M4.45M68.68M30.87M78.31M50.11M15.99M40.94M28.99M
FCF to OCF42.67%616.11%9.04%-90.07%-114.79%-354.02%420.11%464.60%481.41%378.23%3831.45%448.50%-467.30%-256.53%-56.46%9.18%16.60%46.94%-3.07%
Dividend Paid to FCF15.02%-11.26%51.55%-5.76%-46.32%-21.17%-19.22%-56.79%-46.29%-37.08%-8.84%-1.52%-23.70%-10.54%-19.67%45.43%8.50%8.42%-191.07%

Earnings

Report DateMar 31, 2011Jun 30, 2011Nov 30, 2011Feb 29, 2012May 30, 2012Aug 29, 2012Nov 28, 2012Feb 27, 2013May 29, 2013Aug 28, 2013Nov 27, 2013Feb 26, 2014May 28, 2014Aug 26, 2014Oct 26, 2014Feb 28, 2015Apr 26, 2015Aug 26, 2015Oct 26, 2015Feb 28, 2016Apr 29, 2016Aug 26, 2016Oct 22, 2016Feb 25, 2017Apr 18, 2017Aug 22, 2017Oct 29, 2017Feb 26, 2018Apr 24, 2018Aug 17, 2018Oct 22, 2018Apr 26, 2019Aug 23, 2019Oct 23, 2019Feb 6, 2020Apr 25, 2020Aug 14, 2020Oct 20, 2020Mar 25, 2021Apr 27, 2021Aug 30, 2021Oct 28, 2021Mar 18, 2022Apr 28, 2022Aug 10, 2022Oct 24, 2022Mar 29, 2023Apr 24, 2023Aug 25, 2023Oct 25, 2023Mar 29, 2024Apr 24, 2024Aug 27, 2024Oct 25, 2024Dec 31, 2024Apr 11, 2025Aug 25, 2025Oct 29, 2025Mar 28, 2026Apr 27, 2026Aug 28, 2026
EPS Estimate--------------------------0.020.010.01----------0.32---0.020.190.190.190.150.040.190.19-0.080.110.250.06-0.06-0.060.110.07-0.020.11
EPS Actual0.010.050.040.050.020.060.030.060.020.04-0.030.01-0.04-0.01-0.060.21-0.03-0.01-0.03-0.52-0.03-0.09-0.050.20-0.02-0.010.00-0.320.020.030.010.030.030.020.01-0.010.050.240.360.020.180.030.040.060.240.080.120.110.180.06-0.080.010.100.05-0.07-0.070.030.070.010.07-0.04
Surprise-------------------------50.00%-76.00%-3300.00%----------12.50%---100.00%-68.42%26.32%-57.89%-20.00%175.00%-5.26%-68.42%0.00%-90.91%-60.00%-16.67%-16.67%-16.67%-72.73%0.00%-250.00%-136.36%
Timing-------------After-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursPre-market-After-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hours-After-hoursAfter-hours--After-hoursAfter-hours

Key Statistics & Ratios

Market Cap22.76B
Enterprise Value23.01B
Trailing P/E118.58
Forward P/E37.31
PEG Ratio0.00
Price / Sales10.85
Price / Book3.23
EPS0.12
Book Value4.37
Revenue (TTM)2.10B
Gross Profit (TTM)1.59B
EBITDA542.75M
Profit Margin9.00%
Operating Margin-7.33%
Return on Equity1.97%
Return on Assets0.96%
Shares Outstanding1.60B
Shares Float1.47B
Beta0.62
Dividend Yield1.09%
Dividend Rate0.16
Payout Ratio142.33%

Dividends

20262×
0.13Jun 24, 20260.03Jan 9, 2026
20251×
0.01May 28, 2025
20241×
0.01May 30, 2024
20231×
0.01May 11, 2023
20221×
0.03Apr 26, 2022
20211×
0.05May 19, 2021
20201×
0.02Sep 30, 2020
20191×
0.03Jul 23, 2019
20151×
0.01Apr 23, 2015
20141×
0.01May 30, 2014
20131×
0.03Jun 19, 2013
20121×
0.03May 7, 2012
20111×
0.03Sep 16, 2011

Stock Splits

  • Oct 14, 201530:10
  • Apr 23, 201520:10
  • May 30, 201413:10
  • May 7, 201212:10
  • May 5, 201115:10